Novel Epigenetic And Molecular Determinants Of Gastric Cancer Initation And Progression
Funder
National Health and Medical Research Council
Funding Amount
$432,909.00
Summary
Over one million deaths from stomach cancer occur annually. This often fatal disease can be caused by infection with the bacterium H. pylori. I am a molecular biologist seeking to understand how inflammation caused by H. pylori drives a genetic signature which can be used to predict stomach cancer risk. I will also study how a new family of stomach proteins can prevent tumour growth. My research aims to lead new initiatives for early detection and treatment of stomach cancer.
Minimising Infection Risks Associated With Water Exposure And With International Travel: Addressing Data Gaps To Improve Policy And Practice
Funder
National Health and Medical Research Council
Funding Amount
$401,361.00
Summary
This project will provide better understanding of health risks associated with two areas of infectious diseases: i) exposure to water, including water recycling and ii) imported infections associated with international travel. Both these issues are highly topical, and new information about exposure risks is important to help guide appropriate preventive advice.
T Helper Cytokines In Immunity And Organ-specific Autoimmunity
Funder
National Health and Medical Research Council
Funding Amount
$443,946.00
Summary
The overall goal of these studies is to identify mechanisms underlying the effects of cytokines on T cell-mediated immunity, how defects in these processes can result in organ specific autoimmune disease, and whether exploiting these mechanisms may result in improved therapies for individuals with autoimmune diseases. The proposed aims build on my previous work on interleukin-21 and interleukin-21-producing T helper cells in both immunity and autoimmunity.
The Epidemiology And Control Of Sexually Transmitted Infections Within Australia.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Sexually transmitted infections (STIs) such as chlamydia are increasing. Without effective vaccines, STIs can only be controlled by behavioral or screening interventions. This program of research will help us understand how STIs such as chlamydia, Mycoplasma genitalium, HPV and bacterial vaginosis spread among Australians and will help us to determine how best to control them.
Addressing Important Evidence Gaps In The Management Of Severe Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$256,839.00
Summary
There are currently large gaps in the evidence base for management of common severe bacterial infections. My research plan focuses on the most common of these: Staphylococcus aureus infections, bone and joint infections, skin infections, and severe sepsis. In order to both generate important evidence to inform practice, as well as to develop my own skills and experience as an expert in clinical trials, I have initiated randomised controlled trials in each of these areas.
Optimising Interventions For Staphylococcus Aureus And Skin Infections
Funder
National Health and Medical Research Council
Funding Amount
$338,381.00
Summary
Staphylococcal and streptococcal infections are major causes of illness and death, particularly in Indigenous Australians. These include invasive bloodstream infections and skin infections that lead to chronic kidney and heart disease. I will conduct clinical trials to optimise the management of staphylococcal bloodstream infections using novel trial methods, and use genomics and mathematical modelling to understand and reduce the burden of skin infections in Indigenous communities.
Improving The Understanding And Management Of Important Human Bacterial Infections
Funder
National Health and Medical Research Council
Funding Amount
$204,196.00
Summary
This project will focus on two important bacteria, Staphylococcus aureus (Golden Staph), and Enterococcus faecium, both causes of serious infections in hospital and community patients in Australia. Using new technologies, including whole genome sequencing, this project will lead to significant advances in understanding how these bacteria evolve, spread and cause disease. This will lead to new strategies for prevention and management of infections caused by these important bacteria.